What conditions does Nanjing Leads Biolabs Co.,Ltd run trials for?

In our tracked recruiting trials, Nanjing Leads Biolabs Co.,Ltd sponsors trials for Advanced Melanoma, Breast cancer, Lupus.

Clinical trials sponsored by Nanjing Leads Biolabs Co.,Ltd

Recruiting trials

Conditions studied

Phase 1 3Phase 2 2

Condition	Trials
Advanced Melanoma	1
Breast cancer	1
Lupus	1
Melanoma	1
Systemic Lupus Erythematosus	1
Triple Negative Breast Cancer	1

A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
NCT07323173 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 12 locations
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
NCT07281976 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
NCT07099430 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations

Nanjing Leads Biolabs Co.,Ltd is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.